BQGE:F:F-Ossiam Lux Barclays Quantic Global E NR (EUR)

ETF | Others |

Last Closing

USD 131.32

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-8.40 (-1.42%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-1.04 (-1.95%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.19 (-1.23%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-3.21 (-3.01%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.17%)

USD 43.00B
0ZC:F Zscaler Inc

-12.70 (-6.77%)

USD 37.92B
BSND:F Danone SA

+0.40 (+3.03%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.00 (-0.75%)

USD 24.77B

ETFs Containing BQGE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.09% 59% D- 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.09% 58% F 53% F
Trailing 12 Months  
Capital Gain 11.33% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.33% 54% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.48% 62% D 61% D-
Dividend Return 8.48% 59% D- 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.83% 72% C 93% A
Risk Adjusted Return 96.01% 87% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike